Loading company…
Proxybio develops mRNA drug products and synthesis technology.
Proxybio operates a self-developed high-throughput mRNA synthesis platform for producing mRNA drug products. The company was established in 2020 and is based in Shenzhen, China. It raised seed funding from Bio Venture in July 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in